These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 16940069

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Population pharmacokinetics of tigecycline in healthy volunteers.
    Van Wart SA, Cirincione BB, Ludwig EA, Meagher AK, Korth-Bradley JM, Owen JS.
    J Clin Pharmacol; 2007 Jun; 47(6):727-37. PubMed ID: 17519399
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics and safety profile of tigecycline in children aged 8 to 11 years with selected serious infections: a multicenter, open-label, ascending-dose study.
    Purdy J, Jouve S, Yan JL, Balter I, Dartois N, Cooper CA, Korth-Bradley J.
    Clin Ther; 2012 Feb; 34(2):496-507.e1. PubMed ID: 22249106
    [Abstract] [Full Text] [Related]

  • 4. The pharmacokinetic and pharmacodynamic profile of tigecycline.
    Meagher AK, Ambrose PG, Grasela TH, Ellis-Grosse EJ.
    Clin Infect Dis; 2005 Sep 01; 41 Suppl 5():S333-40. PubMed ID: 16080071
    [Abstract] [Full Text] [Related]

  • 5. Exposure-response analyses of tigecycline efficacy in patients with complicated skin and skin-structure infections.
    Meagher AK, Passarell JA, Cirincione BB, Van Wart SA, Liolios K, Babinchak T, Ellis-Grosse EJ, Ambrose PG.
    Antimicrob Agents Chemother; 2007 Jun 01; 51(6):1939-45. PubMed ID: 17353238
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Safety and efficacy of intravenous tigecycline in subjects with secondary bacteremia: pooled results from 8 phase III clinical trials.
    Gardiner D, Dukart G, Cooper A, Babinchak T.
    Clin Infect Dis; 2010 Jan 15; 50(2):229-38. PubMed ID: 20025527
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of tigecycline monotherapy compared with vancomycin plus aztreonam in patients with complicated skin and skin structure infections: Results from a phase 3, randomized, double-blind trial.
    Sacchidanand S, Penn RL, Embil JM, Campos ME, Curcio D, Ellis-Grosse E, Loh E, Rose G.
    Int J Infect Dis; 2005 Sep 15; 9(5):251-61. PubMed ID: 16099700
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Safety and tolerability of tigecycline for the treatment of complicated skin and soft-tissue and intra-abdominal infections: an analysis based on five European observational studies.
    Guirao X, Sánchez García M, Bassetti M, Bodmann KF, Dupont H, Montravers P, Heizmann WR, Capparella MR, Simoneau D, Eckmann C.
    J Antimicrob Chemother; 2013 Jul 15; 68 Suppl 2():ii37-44. PubMed ID: 23772045
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Population pharmacokinetics and pharmacodynamics of garenoxacin in patients with community-acquired respiratory tract infections.
    Van Wart S, Phillips L, Ludwig EA, Russo R, Gajjar DA, Bello A, Ambrose PG, Costanzo C, Grasela TH, Echols R, Grasela DM.
    Antimicrob Agents Chemother; 2004 Dec 15; 48(12):4766-77. PubMed ID: 15561855
    [Abstract] [Full Text] [Related]

  • 16. Absence of an interaction between tigecycline and digoxin in healthy men.
    Zimmerman JJ, Harper DM, Matschke K, Speth JL, Raible DG, Fruncillo RJ.
    Pharmacotherapy; 2007 Jun 15; 27(6):835-44. PubMed ID: 17542766
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae.
    Vasilev K, Reshedko G, Orasan R, Sanchez M, Teras J, Babinchak T, Dukart G, Cooper A, Dartois N, Gandjini H, Orrico R, Ellis-Grosse E, 309 Study Group.
    J Antimicrob Chemother; 2008 Sep 15; 62 Suppl 1():i29-40. PubMed ID: 18684704
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of tigecycline for the treatment of complicated intra-abdominal infections in real-life clinical practice from five European observational studies.
    Eckmann C, Montravers P, Bassetti M, Bodmann KF, Heizmann WR, Sánchez García M, Guirao X, Capparella MR, Simoneau D, Dupont H.
    J Antimicrob Chemother; 2013 Jul 15; 68 Suppl 2():ii25-35. PubMed ID: 23772043
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.